BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KLF6, RP11-184A2_1, 1316, ENSG00000067082, ST12, DKFZp686N0199, CPBP, Zf9, COPEB, ZF9, PAC1, GBF, BCD1 AND Prognosis
8112 results:

  • 1. Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment.
    Xin J; Gu D; Li S; Qian S; Cheng Y; Shao W; Ben S; Chen S; Zhu L; Jin M; Chen K; Hu Z; Zhang Z; Du M; Shen H; Wang M
    Nat Commun; 2024 Apr; 15(1):3042. PubMed ID: 38589358
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
    Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
    J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and PML bodies in colorectal cancer cells.
    El Osmani N; Prévostel C; Picque Lasorsa L; El Harakeh M; Radwan Z; Mawlawi H; El Sabban M; Shirinian M; Dassouki Z
    Epigenetics; 2024 Dec; 19(1):2337142. PubMed ID: 38583183
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effect of probiotics and synbiotics on complications of wound infection after colorectal surgery: A meta-analysis.
    Jiang J; Ren F
    Int Wound J; 2024 Apr; 21(4):e14838. PubMed ID: 38577937
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of severe postoperative complications on the prognosis of older patients with colorectal cancer: a two-center retrospective study.
    Matsubara D; Soga K; Ikeda J; Kumano T; Mitsuda M; Konishi T; Komatsu S; Shimomura K; Taniguchi F; Shioaki Y; Otsuji E
    BMC Gastroenterol; 2024 Apr; 24(1):125. PubMed ID: 38566007
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A new clinical model for predicting lymph node metastasis in T1 colorectal cancer.
    Wang K; He H; Lin Y; Zhang Y; Chen J; Hu J; He X
    Int J Colorectal Dis; 2024 Apr; 39(1):46. PubMed ID: 38565736
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of depression and anxiety on colorectal cancer-related mortality: a systematic review and meta-analysis based on univariate and multivariate data.
    Xia S; Zhu Y; Luo L; Wu W; Ma L; Yu L; Li Y
    Int J Colorectal Dis; 2024 Apr; 39(1):45. PubMed ID: 38563889
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.
    Lee KH; Yang IJ; Ha GW; Lee J; Park YY; Lee SH; Lee JM; Bae JH; Park EJ; Kim H; Kim KY; An S; Kim IY; Kim JY
    BMC Cancer; 2024 Mar; 24(1):397. PubMed ID: 38553680
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
    Rao C; Tong J; Yang Y
    Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer.
    Topi G; Satapathy SR; Ghatak S; Hellman K; Ek F; Olsson R; Ehrnström R; Lydrup ML; Sjölander A
    Cell Commun Signal; 2024 Mar; 22(1):198. PubMed ID: 38549115
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
    Karaca M; Salim E; Alemdar MS; Deniz Karaca Ö; Arıcı MÖ
    Med Sci Monit; 2024 Mar; 30():e943750. PubMed ID: 38544312
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic colorectal cancer.
    Gherman A; Bolundut D; Ecea R; Balacescu L; Curcean S; Dina C; Balacescu O; Cainap C
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541123
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
    Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
    J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phosphoglycerate Kinase 1: An Effective Therapeutic Target in cancer.
    Qiu A; Wen X; Zou Q; Yin L; Zhu S; Sheng Y; He Y; Liu Q; Luo D; Guo Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):92. PubMed ID: 38538272
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High-risk Patients With colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Beppu T; Yamamura K; Masuda T; Miyamoto H; Nasu J; Saito S; Doi K; Katsumori T; Oda T; Isiko T
    Anticancer Res; 2024 Apr; 44(4):1533-1539. PubMed ID: 38537970
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV colorectal cancer Survival.
    Satoyoshi T; Hirohashi Y; Okuya K; Miyo M; Akizuki E; Ishii M; Miura R; Kubo T; Murata K; Kanaseki T; Tsukahara T; Takemasa I; Torigoe T
    Anticancer Res; 2024 Apr; 44(4):1603-1610. PubMed ID: 38537969
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. colorectal cancer Patients' Reported Frequency, Content, and Satisfaction with Advance Care Planning Discussions.
    Hussein S; Lim CA; Manokaran T; Kassam S; Earp M; Tang PA; Karim S; Biondo P; Watanabe SM; Sinnarajah A; Tan A; Simon J
    Curr Oncol; 2024 Feb; 31(3):1235-1245. PubMed ID: 38534925
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and FOXP3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 406.